Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Quemliclustat by Arcus Biosciences for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Quemliclustat is under clinical development by Arcus Biosciences and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to...
Quemliclustat by Arcus Biosciences for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Quemliclustat is under clinical development by Arcus Biosciences and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
Quemliclustat by Arcus Biosciences for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
Quemliclustat is under clinical development by Arcus Biosciences and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...
Quemliclustat by Arcus Biosciences for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Quemliclustat is under clinical development by Arcus Biosciences and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...